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INTRODUCTION:  Basaloid  squamous  cell  carcinoma  of  the  oesophagus  (BSCCE)  is  a relatively  rare  variant
of oesophageal  malignancy.  There  are  no established  treatment  strategies  for pulmonary  metastases  of
BSCCE.
PRESENTATION  OF  CASE:  A  72-year-old  man  underwent  oesophagectomy  and  subsequently  received  a
pathological  diagnosis  of  stage  IIIA (T3N1M0)  BSCCE  according  to Union  for  International  Cancer  Control.
One  year  and  5 months  later,  he  underwent  partial  resection  of the  right  lung  because  of  metastasis  of the
BSCCE.  One  year and  6  months  after  the  pulmonary  resection,  recurrence  in  the  right  lung  was  observed.
The  patient  was  treated  with  concurrent  chemoradiotherapy  using  cisplatin  and  5-ﬂuorouracil,  and  the
lesion  completely  disappeared.  The  patient  is  doing  well  without  recurrence  5  years  after  chemoradio-
therapy.
DISCUSSION:  In our  case,  the  recurrent  lesion  in  the  right lung  was  observed  after  the  pulmonary  resection.
It  is difﬁcult  to determine  whether  the  recurrent  lesion  is  solitary  or multiple  and  whether  it  is  a local
or  pleural  metastasis.  Therefore,  surgical  indication  must  be decided  carefully.  Systemic  chemotherapy
or  radiotherapy  is  useful  to treat  BSCCE  metastasis,  however,  appropriate,  but which  agents  and  their
regimens  are  appropriate  is  not  clear.  Concurrent  chemotherapy  using  cisplatin  and  5-ﬂuorouracil  and
radiotherapy  for pulmonary  BSCCE  metastases  may  provide  curative  therapy  and  should  be considered.
CONCLUSION:  This  report  describes  a case  of recurrent  pulmonary  metastasis  after  pulmonary  resection
of  BSCCE  metastasis,  successfully  treated  by concurrent  chemotherapy  and  radiotherapy.  Further  studies
are required  to establish  the  indications  and  efﬁcacy  of  these  therapeutic  approaches.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Basaloid squamous cell carcinoma (BSCC) was ﬁrst described
n 1986 by Wain et al. [1]. BSCC of the oesophagus (BSCCE) is
n uncommon form of squamous cell carcinoma of the oesopha-
us (SCCE) and a relatively rare oesophageal malignancy. Previous
eports indicate that the incidence of BSCCE varies between 0.068
nd 11.3% [2,3]. In our institution, 1193 patients underwent
Abbreviations: BSCCE, basaloid squamous cell carcinoma of the oesophagus; CT,
omputed tomography; FDG-PET, 18F-2-ﬂuoro-2-deoxy-d-glucose positron emis-
ion  tomography; SCCE, squamous cell carcinoma of the oesophagus; SUVmax,
aximum standardised uptake value.
∗ Corresponding author. Fax: +81 22 717 7217.
E-mail address: torun@med.tohoku.ac.jp (T. Nakano).
ttp://dx.doi.org/10.1016/j.ijscr.2015.11.013
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
oesophagectomy from 1986 to 2013, 50 (4.2%) of whom were diag-
nosed with BSCCE following pathological examination of resected
specimens. Treatment strategies for conventional SCCE are cur-
rently commonly used to treat BSCCE [4]. Treatment guidelines
for BSCCE and metastatic lesions are not yet established because
of the limited number of studies. Therefore, few reports discuss
the treatment strategies for pulmonary metastasis of BSCCE. Here,
we present the ﬁrst case of a recurrent pulmonary metastasis of
BSCCE after pulmonary resection successfully treated with con-
current chemoradiotherapy resulting in long-term recurrence-free
survival. Furthermore, we  conducted a literature review relevant
to this case.roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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rig. 1. Oesophagogastroduodenoscopy ﬁndings A protruding-type tumour was
etected in the middle third of the thoracic oesophagus. Pathological examination
f biopsy specimens indicated squamous cell carcinoma.
. Presentation of case
A 72-year-old man  complaining of dysphagia was diagnosed
ith oesophageal cancer by oesophagogastroduodenoscopy and
dmitted to our hospital. A protruding-type tumor was observed
n the middle third of the thoracic oesophagus. Pathological exam-
nation of biopsy specimens revealed SCCE (Fig. 1). Computed
omography (CT) demonstrated swelling of the left gastric artery
ymph nodes without evidence of invasion into adjacent structures
r metastasis to distant organs. Curative oesophagectomy with
ymph node dissection was performed thoracoscopically. Macro-
copic analysis of the resected specimen revealed a 40 × 35 mm
ig. 2. Macroscopic and pathological ﬁndings of resected oesophageal specimen (a) Macr
nd  ulcerated protruding lesion situated in the middle third of the thoracic oesophagus. 
hat  was  not stained by iodine was identiﬁed. (c and d) Pathological examination reveal
ound  to oval nuclei and a high nuclear-to-cytoplasmic ratio forming nests and cord-like Fig. 3. Follow-up computed tomography showing a 10-mm nodule in the upper
lobe  of the right lung (arrows).
tumor in the middle third of the thoracic oesophagus, and three
multiple lesions were detected on the anal side of the main
tumor (Figs. 2a and b). The pathological diagnosis was BSCCE, and
macroscopic evaluation revealed multiple lesions (Figs. 2c and d).
Lymphatic invasion and venous invasion were also detected patho-
logically. Lymph node metastases were detected along the left
recurrent laryngeal nerve and left gastric artery and diagnosed
as pathological stage IIIA (T3N1M0) according to the seventh edi-
tion of Union for International Cancer Control. Postoperatively, an
anastomotic leak was observed and successfully managed with
conservative treatment.
Fourteen months later, a follow-up CT detected a 10-mm nod-
ule in the upper lobe of the right lung (Fig. 3) with a maximum
standardised uptake value (SUVmax) of 2.0 on 18F-2-ﬂuoro-
2-deoxy-d-glucose positron emission tomography (FDG-PET).
Furthermore, SCC antigen levels were elevated at 2.3 ng/mL (nor-
oscopic view of the resected specimen demonstrating a 40 × 35 mm pedunculated
(b) Three skip lesions were observed on the anal side of the main tumour. An area
ed inﬁltrating cancer cells with characteristic oesophageal basal cell morphology,
arrangements.
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cig. 4. Microscopic view of BSCCE lesion in resected pulmonary tissue (arrowheads)
he pulmonary lesion was  pathologically diagnosed as a metastasis derived from the
SCCE.
al  range, 0.00–1.50 ng/mL); therefore, the lesion was diagnosed
s a BSCCE metastasis. No other metastases were found on sys-
emic examination. Thoracoscopic partial resection of the upper
obe of the right lung was performed. The pulmonary lesion was
athologically diagnosed as a metastasis derived from the BSCCE
Fig. 4), and there was no cancer in the surgical margin. Eighteen
onths after the second surgery, CT revealed a tumor in the right
ulmonary apex (Fig. 5a) with a SUVmax of 12.2 on FDG-PET. These
esults suggested that the BSCCE had metastasised again. Although,
t was difﬁcult to determine whether the lung tumor was a local
ecurrence or a pleural lung metastasis of BSCCE, it was  consid-
red to be another pleural lung metastasis on the basis of previous
perative ﬁndings and the surgical specimen.
Surgical resection was considered challenging because the
esion was in close proximity to the right subclavian artery and
ein. Therefore, the patient was treated with intravenous cisplatin,
0 mg/m2/day on days 1 and 29 and was continuously treated with
ntravenous 5-ﬂuorouracil, 700 mg/m2/day from days 1 to 4 and 29
o 32. In addition, concurrent radiotherapy of 60 Gy (30 fractions of
 Gy, 5 days/week) was administered. Diagnostic imaging revealed
hat the metastatic lesion disappeared completely (Fig. 5b). The
atient is doing well without any sign of recurrence 5 years after
hemoradiotherapy.
. DiscussionBSCCE is a relatively rare oesophageal malignancy. Previous
eports indicate that the incidence of BSCCE varies between 0.068
nd 11.3% [2,3]. In general, the prognosis of BSCCE has been
ig. 5. Computed tomography (CT) imaging of the recurrent lesion (a) Tumour in the
hemoradiotherapy demonstrating disappearance of the metastatic lesion with no evidenPEN  ACCESS
ery Case Reports 17 (2015) 151–154 153
reported to be worse than that of SCCE because of high proliferative
activity and a high incidence of distant metastases [5,6].
Oesophageal cancer patients with haematogenous recurrence
have a poorer prognosis than patients with locoregional recur-
rence [7]. Outcomes following pulmonary metastasectomy for
oesophageal cancer metastases are unclear; therefore, it is con-
troversial whether surgery is an effective treatment for metastatic
oesophageal cancer. Ichikawa et al. reported acceptable outcomes
following operative intervention for metachronous pulmonary
metastasis from oesophageal carcinoma (including SCC and ade-
nocarcinoma) with predicted 1-, 3-, and 5- year overall survival
rates after pulmonary metastasectomy of 73.9%, 43.5%, and
43.5%, respectively, and a median survival time of 28.7 months
[8]. Shiono et al. reported that pulmonary metastasectomy for
oesophageal cancer (including SCC, adenocarcinoma and carci-
nosarcoma) should be considered in selected patients with a
disease-free interval of >12 months [9]. The prognosis of patients
treated non-operatively for pulmonary metastasis is also unclear
as data on the beneﬁt of surgical resection of BSCCE pulmonary
metastases is currently lacking.
To the best of our knowledge, three successful cases of resected
pulmonary BSCCE metastases without involvement of distant
organs have been reported [4,10,11]. Surgical intervention may
be considered in patients likely to tolerate operative therapy with
solitary metachronous pulmonary BSCCE metastases.
In our case, a recurrent lesion in the right lung was observed
after the pulmonary resection for metachronous pulmonary BSCCE
metastasis. It is difﬁcult to determine whether the recurrent lesion
in the lung is solitary or multiple and whether it is a local recur-
rence or pleural metastasis of BSCCE. Pulmonary metastasis is
often detected as multiple lesions or in combination with extrapul-
monary metastases. The utility of surgical intervention for BSCCE
metastases remains controversial; further studies are required to
assess the biology of metastatic lesions and the efﬁcacy of pul-
monary metastasectomy.
At present, treatment regimens for BSCCE are usually similar
to those employed for typical SCCE [4], for one reason, because
of the difﬁculty in pre-treatment diagnosis [12]. Cisplatin and 5-
ﬂuorouracil chemotherapy is concurrently used with conventional
radiotherapy protocols developed for advanced or recurrent SCCE
[13]. There have been previous reports about use of chemotherapy
and radiotherapy in the treatment of BCSSE metastasis. Nishimura
et al. reported that hepatic BSCCE metastases were successfully
treated by regional chemotherapy via the hepatic artery using
5-ﬂuorouracil [3]. Shibata et al. reported that splenic and para-
clavicular lymph node BSCCE metastasis was  successfully treated
by systemic chemotherapy using 5-ﬂuorouracil and cisplatin [14].
Harada et al. achieved a complete response in patients with
metachronous endobronchial BSCCE metastasis using chemoradio-
therapy comprising docetaxel, cisplatin, 5-ﬂuorouracil and 60 Gy of
irradiation [15]. In a retrospective analysis of 142 cases of BSCCE,
 right pulmonary apex. (b) CT scan performed 5 years following completion of
ce of recurrence.
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hang et al. reported the frequency of locoregional recurrence to
e signiﬁcantly higher in patients who did not receive radiotherapy
han that in patients receiving radiotherapy [16]. However, there
re few reports regarding successful chemotherapy or radiother-
py for pulmonary metastasis of BSCCE. Here, we  presented a case
uccessfully treated with concurrent chemoradiotherapy for recur-
ent pulmonary metastasis of BSCCE. The combination of cisplatin
nd 5-ﬂuorouracil may  have utility in patients with pulmonary
SCCE metastasis. Chemotherapy using cisplatin and 5-ﬂuorouracil
ith concurrent radiotherapy may  provide improved prognosis
nd should be considered for the treatment of BSCCE lung metas-
asis. Further studies are required in the future to establish the
ndications and efﬁcacy of this therapeutic approach.
. Conclusion
We  presented a case of recurrent pulmonary metastasis
fter resection of pulmonary metastasis of BSCCE successfully
reated with concurrent chemoradiotherapy resulting in 5 years
f recurrence-free survival. Concurrent chemotherapy using cis-
latin and 5-ﬂuorouracil and radiotherapy for pulmonary BSCCE
etastases may  provide improved prognosis or curative therapy
nd should be considered for the treatment of this disease.
onsent
Written informed consent was obtained from the patient for
ublication of this case report and accompanying images. A copy
f the written consent is available for review by the Editor-in-Chief
f this journal on request.
onﬂict of interest
None.
unding
This work was not supported by any fund.
thical approval
This work does not require a deliberation by the ethics commit-
ee.
uthors contribution
Hirotaka Ishida and Toru Nakano are the main authors of
his article; Toru Nakano, Tadashi Sakurai, Yusuke Taniyama, and
akashi Kamei were attending doctors and performed clinical
reatment including surgical operation; Fumiyoshi Fujishima and
ironobu Sasano are responsible for pathological analysis; Chiaki
ato, Toshiaki Fukutomi, Kuroudo Kamiya, Yohei Ozawa, Hironobu
[
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
ery Case Reports 17 (2015) 151–154
Sasano, and Noriaki Ohuchi reviewed the manuscript; all authors
have read and approved the ﬁnal manuscript.
Guarantor
Toru Nakano and Noriaki Ohuchi accept full responsibility for
the work and had controlled the decision to publish.
References
[1] S.L. Wain, R. Kier, R.T. Vollmer, E.H. Bossen, Basaloid-squamous carcinoma of
the  tongue, hypopharynx, and larynx: report of 10 cases, Hum. Path. 17
(1986) 1158–1166.
[2] S.B. Chen, H.R. Weng, G. Wang, J.S. Yang, W.P. Yang, H.  Li, et al., Basaloid
squamous cell carcinoma of the esophagus, J. Cancer Res. Clin. Oncol. 138
(2012) 1165–1171.
[3] W.  Nishimura, Y. Naomoto, K. Hamaya, S. Toda, K. Miyagi, N. Tanaka,
Basaloid-squamous cell carcinoma of the esophagus: diagnosis based on
immunohistochemical analysis, J. Gastroenterol. Hepatol. 16 (2001) 586–590.
[4] T. Kosaka, A. Mogi, E. Yamaki, T. Miyazaki, H. Kuwano, Surgical resection of a
solitary pulmonary metastasis from basaloid squamous cell carcinoma of the
esophagus: a case report, Ann. Thorac. Cardiovasc. Surg. 20 (2014) 646–649.
[5] I.M. Schaefer, C. Enders, A. Polten, F. Haller, A.M. Frolich, S. Cameron, et al.,
Common genomic aberrations in basaloid squamous cell carcinoma and
carcinosarcoma of the esophagus detected by CGH and array CGH, Am.  J. Clin.
Pathol. 135 (2011) 579–586.
[6] J.X. Chen, Q. Tang, H.N. Zhu, Y.D. Zheng, [Diagnosis and treatment of basaloid
squamous cell carcinoma of the esophagus], Zhonghua zhong liu za zhi [Chin.
J.  Oncol.] 30 (2008) 392–395.
[7] S. Nakagawa, T. Kanda, S. Kosugi, M.  Ohashi, T. Suzuki, K. Hatakeyama,
Recurrence pattern of squamous cell carcinoma of the thoracic esophagus
after extended radical esophagectomy with three-ﬁeld lymphadenectomy, J.
Am.  Coll. Surg. 198 (2004) 205–211.
[8] H. Ichikawa, S. Kosugi, S. Nakagawa, T. Kanda, M.  Tsuchida, T. Koike, et al.,
Operative treatment for metachronous pulmonary metastasis from
esophageal carcinoma, Surgery 149 (2011) 164–170.
[9] S. Shiono, M.  Kawamura, T. Sato, K. Nakagawa, J. Nakajima, I. Yoshino, et al.,
Disease-free interval length correlates to prognosis of patients who
underwent metastasectomy for esophageal lung metastases, J. Thorac. Oncol.
3 (2008) 1046–1049.
10] M.  Takemura, K. Yoshida, Y. Fujiwara, K. Sakurai, M.  Takii, A case of long-term
survival after pulmonary resection for metachronous pulmonary metastasis
of  basaloid squamous cell carcinoma of the esophagus, Int. J. Surg. Case Rep. 3
(2012) 451–454.
11] H. Shibasaki, A. Yoshino, N. Okada, T. Mizobuchi, K. Yoshimura, H. Fukuda,
et  al., A case of basaloid carcinoma of the esophagus with a solitary lung
metastasis for which thoracoscopic partial lung resection was performed,
Gen. Thorac. Cardiovasc. Surg. 60 (2012) 673–679.
12] S. Saito, Y. Hosoya, T. Zuiki, M.  Hyodo, A. Lefor, N. Sata, et al., A
clinicopathological study of basaloid squamous carcinoma of the esophagus,
Esophagus 6 (2009) 177–181.
13] K. Hayashi, N. Ando, H. Watanabe, H. Ide, K. Nagai, N. Aoyama, et al., Phase II
evaluation of protracted infusion of cisplatin and 5-ﬂuorouracil in advanced
squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology
Group (JEOG) trial (JCOG9407), Jpn. J. Clin. Oncol. 31 (2001) 419–423.
14] Y. Shibata, E. Baba, H. Ariyama, R. Miki, N. Ogami, S. Arita, et al., Metastatic
basaloid-squamous cell carcinoma of the esophagus treated by 5-ﬂuorouracil
and cisplatin, World J. Gastroenterol. 13 (2007) 3634–3637.
15] K. Harada, M. Watanabe, Y. Nagai, Y. Baba, M.  Iwatsuki, Y. Miyamoto, et al.,
Endotracheal metastasis from basaloid squamous carcinoma of the
esophagus, Esophagus 9 (2012) 54–57.
16] B.-H. Zhang, G.-Y. Cheng, Q. Xue, S.-G. Gao, K.-L. Sun, Y.-G. Wang, et al.,
Clinical outcomes of basaloid squamous cell carcinoma of the esophagus: a
retrospective analysis of 142 cases, Asian Pac. J. Cancer Prev. 14 (2013)
1889–1894.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
